Literature DB >> 20300772

Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.

Fredrik Petersson1, Zoran Gatalica, Petr Grossmann, Maria Delia Perez Montiel, Isabel Alvarado Cabrero, Stela Bulimbasic, Anthony Swatek, Lubomir Straka, Tomas Tichy, Milan Hora, Naoto Kuroda, Ben Legendre, Michal Michal, Ondrej Hes.   

Abstract

Hybrid oncocytic/chromophobe tumors (HOCT) of the kidney have been described in patients with Birt-Hogg-Dubé syndrome (BHD) and in association with renal oncocytosis without BHD. HOCT in patients without evidence of BHD or renal oncocytosis is exceedingly rare, and these cases have been poorly characterized. We have identified and studied 14 cases of HOCT from previously diagnosed renal oncocytomas (398 cases) and chromophobe renal cell carcinomas (351 cases) without evidence of BHD or renal oncocytosis. Immunohistochemical, ultrastructural, and molecular genetic studies analyzing numerical chromosomal changes, loss of heterozygosity for chromosome 3p, and mutation status of VHL, c-kit, PDGFR, and folliculin (FLCN) genes were performed. HOCTs were identified in nine men and five women (age range 40-79 years). The size of tumors ranged from 2 to 11 cm. All tumors displayed a solid alveolar architecture and were composed of cells with abundant granular eosinophilic oncocytic cytoplasm with perinuclear halos. Occasional binucleated neoplastic cells were present, but irregular, hyperchromatic, wrinkled (raisinoid) nuclei were absent. The cytoplasm contained numerous mitochondria of varying sizes, but only sparse microvesicles with amorphic lamellar content were found. Tumors were positive for CK7 (12/14), AE1-AE3 (14/14), anti-mitochondrial antigen (14/14), E-cadherin (11/13), parvalbumin (12/14), and epithelial membrane antigen (14/14). Tumors were generally negative for racemase, CK20, CD10, and carboanhydrase IX. Interphase fluorescence in situ hybridization revealed multiple chromosomal losses and gains with a median of four (range 1-9) chromosomal aberrations per case. Monosomy of chromosome 20 was common and found in 7 of 14 cases. Monosomy of chromosomes 6 and 9 was present in 4 of 14 cases each, of which two cases displayed monosomy for both chromosomes 6 and 9. Polysomy of chromosomes 10, 21, and 22 was found in 4/14 cases each, of which one case displayed polysomy for all these three chromosomes. No pathogenic mutations were found in the VHL, c-kit, PDGFR, and folliculin (FLCN) genes. (1) We have shown that hybrid oncocytic/chromophobe tumors of the kidney do occur, albeit rarely, outside the Birt-Hogg-Dubé syndrome and without associated renal oncocytosis. (2) These tumors constitute a relatively homogenous group with histomorphologic features of both chromophobe renal cell carcinoma and renal oncocytoma. (3) Sporadic hybrid oncocytic/chromophobe renal tumors are characterized by multiple numerical aberrations (both mono- and polysomies) of chromosomes 1, 2, 6, 9, 10, 13, 17, 21, and 22 and lack of mutations in the VHL, c-kit, PDGFRA, and FLCN genes. (4) The tumors seem to behave indolently as no evidence of malignant behavior was documented in our series, although admittedly, the follow-up was too short to fully elucidate the biological nature of this rare neoplasm. At worst, these tumors could have a low malignant potential, which only can be found out with longer follow-up.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20300772     DOI: 10.1007/s00428-010-0898-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  23 in total

1.  Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.

Authors:  J Herbers; D Schullerus; J Chudek; P Bugert; H Kanamaru; J Zeisler; B Ljungberg; M Akhtar; G Kovacs
Journal:  J Pathol       Date:  1998-01       Impact factor: 7.996

Review 2.  Renal oncocytosis.

Authors:  Yoji Nagashima; Toshiyuki Mitsuya; Ko-ich Shioi; Sumio Noguchi; Takeshi Kishida; Atsushi Hamano; Yoshiharu Ohgo; Yukio Tsuura; Toru Ogawa; Ichiro Aoki; Masahiro Yao
Journal:  Pathol Int       Date:  2005-04       Impact factor: 2.534

3.  Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome.

Authors:  Christian P Pavlovich; Robert L Grubb; Kathleen Hurley; Gladys M Glenn; Jorge Toro; Laura S Schmidt; Carlos Torres-Cabala; Maria J Merino; Berton Zbar; Peter Choyke; McClellan M Walther; W Marston Linehan
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

4.  Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma.

Authors:  T Murakami; F Sano; Y Huang; A Komiya; M Baba; Y Osada; Y Nagashima; K Kondo; N Nakaigawa; T Miura; Y Kubota; M Yao; T Kishida
Journal:  J Pathol       Date:  2007-04       Impact factor: 7.996

5.  Comparative genomic hybridization for genetic analysis of renal oncocytomas.

Authors:  J C Presti; H Moch; V E Reuter; D Huynh; F M Waldman
Journal:  Genes Chromosomes Cancer       Date:  1996-12       Impact factor: 5.006

6.  Chromophobe renal cell carcinoma: useful diagnostic application of imprint cytology and fluorescence in situ hybridization of chromosomes 10 and 21 in two cases of typical and eosinophilic variants.

Authors:  Naoto Kuroda; Kazunobu Katto; Tadanori Yamaguchi; Takako Kawada; Yoshiaki Imamura; Ondrej Hes; Michal Michal; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

7.  Early onset of renal cancer in a family with Birt-Hogg-Dubé syndrome.

Authors:  I Kluijt; D de Jong; H J Teertstra; P H Axwijk; J J P Gille; K Bell; A van Rens; A W G van der Velden; L Middelton; S Horenblas
Journal:  Clin Genet       Date:  2009-03-23       Impact factor: 4.438

8.  Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.

Authors:  Matthias Waldert; Tobias Klatte; Andrea Haitel; Mehmet Ozsoy; Joerg Schmidbauer; Michael Marberger; Mesut Remzi
Journal:  Eur Urol       Date:  2009-05-18       Impact factor: 20.096

9.  Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical and genetic features.

Authors:  Ondrej Hes; Michal Michal; Radek Síma; Tomás Vanecek; Matteo Brunelli; Guido Martignoni; Naoto Kuroda; Isabel Alvarado Cabrero; Delia Perez-Montiel; Milan Hora; Tomás Urge; Miroslav Dvorák; Marie Jarosová; Ximing Yang
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

10.  Hybrid tumour 'oncocytoma-chromophobe renal cell carcinoma' of the kidney: a report of seven sporadic cases.

Authors:  Nicolas B Delongchamps; Louise Galmiche; David Eiss; Yannick Rouach; Benoit Vogt; Marc-Olivier Timsit; Annick Vieillefond; Arnaud Méjean
Journal:  BJU Int       Date:  2009-01-20       Impact factor: 5.588

View more
  47 in total

1.  [Kidney tumours].

Authors:  H Moch
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

2.  Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy.

Authors:  Serge Ginzburg; Robert Uzzo; Tahseen Al-Saleem; Essel Dulaimi; John Walton; Anthony Corcoran; Elizabeth Plimack; Reza Mehrazin; Jeffrey Tomaszewski; Rosalia Viterbo; David Y T Chen; Richard Greenberg; Marc Smaldone; Alexander Kutikov
Journal:  J Urol       Date:  2013-07-27       Impact factor: 7.450

Review 3.  Diagnostic approach to eosinophilic renal neoplasms.

Authors:  Oleksandr N Kryvenko; Merce Jorda; Pedram Argani; Jonathan I Epstein
Journal:  Arch Pathol Lab Med       Date:  2014-11       Impact factor: 5.534

4.  Renal cell neoplasm of oncocytosis: a type of unclassified renal cell carcinoma.

Authors:  Masatake Shinohara; Shoji Samma; Yoshihiro Matsumoto; Yoriaki Kagebayashi; Yasushi Nakai; Kazumasa Torimoto; Keiji Shimada
Journal:  CEN Case Rep       Date:  2013-04-19

5.  "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.

Authors:  Huiying He; Kiril Trpkov; Petr Martinek; Ozlem Tanas Isikci; Cristina Maggi-Galuzzi; Reza Alaghehbandan; Anthony J Gill; Maria Tretiakova; Jose Ignacio Lopez; Sean R Williamson; Delia Perez Montiel; Maris Sperga; Eva Comperat; Fadi Brimo; Ali Yilmaz; Kristyna Pivovarcikova; Kveta Michalova; David Slouka; Kristyna Prochazkova; Milan Hora; Michael Bonert; Michal Michal; Ondrej Hes
Journal:  Virchows Arch       Date:  2018-09-19       Impact factor: 4.064

Review 6.  [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].

Authors:  C Lüders; G Kristiansen
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

7.  Classification of solid renal tumor with oncocytic/eosinophilic cytoplasm: is hybrid oncocytic/chromophobe renal tumor a subtype of oncocytoma, chromophobe renal cell carcinoma, or a distinct tumor entity?

Authors:  Shuji Mikami; Naoto Kuroda; Yoji Nagashima; Chisato Ohe; Hiroyuki Hayashi; Ryuichi Mizuno; Mototsugu Oya; Kaori Kameyama
Journal:  Ann Transl Med       Date:  2019-12

Review 8.  Renal cell carcinoma: Evolving and emerging subtypes.

Authors:  Suzanne M Crumley; Mukul Divatia; Luan Truong; Steven Shen; Alberto G Ayala; Jae Y Ro
Journal:  World J Clin Cases       Date:  2013-12-16       Impact factor: 1.337

9.  Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas.

Authors:  Nicolas Poté; Annick Vieillefond; Jérôme Couturier; Sandrine Arrufat; Isabelle Metzger; Nicolas B Delongchamps; Philippe Camparo; Florence Mège-Lechevallier; Vincent Molinié; Mathilde Sibony
Journal:  Virchows Arch       Date:  2013-05-25       Impact factor: 4.064

10.  Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors.

Authors:  Naoto Kuroda; Azusa Tanaka; Tadanori Yamaguchi; Kotaro Kasahara; Keishi Naruse; Yosuke Yamada; Kanako Hatanaka; Nobuo Shinohara; Yoji Nagashima; Shuji Mikami; Mototsugu Oya; Takeru Hamashima; Michal Michal; Ondrej Hes
Journal:  Med Mol Morphol       Date:  2013-01-22       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.